Omega-3 fatty acids don't improve heart's ability to relax and efficiently refill with blood
Over the past three decades, researchers have firmly established that the omega-3 fatty acids in fish oil, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have healthy effects on the heart. Omega-3 fatty acids seem to help both in preventing cardiovascular disease as well as in preventing future heart attacks, strokes, and other adverse events in people who have established cardiovascular disease. These findings have been so strong that the American Heart Association now recommends eating fish or taking fish oil as a preventive measure both for healthy individuals and those with cardiovascular disease. However, the mechanism behind omega-3's healthy effects isn't yet known.
In a new study, Zhaohui Gao, Robert P. Feehan, Lawrence I. Sinoway, and Kevin D. Monahan of the Penn State College of Medicine investigated whether part of omega-3's benefits might rely on improving cardiac diastolic functionthe ability of the heart to relax and efficiently refill with blood at each beat, which declines with age. Their findings show that taking an omega-3 supplement daily for three months didn't change diastolic function in older adults, suggesting that omega-3's benefits might fall on other aspects of cardiovascular function.
An abstract of their study entitled, "Three-Month Omega-3 Fatty Acid Supplementation Does Not Improve Cardiac Diastolic Function in Healthy Older Adults," will be discussed at the meeting Experimental Biology 2012 being held April 21-25 at the San Diego Convention Center. The abstract is sponsored by the American Physiological Society (APS), one of six scientific societies sponsoring the conference which last year attracted some 14,000 attendees.
No Effect on Diastolic Function
To investigate omega-3's effects on diastolic function, the researchers recruited 11 healthy adults with an average age of 66 yearsa prime age group in which hearts begin to show signs of aging, including diastolic dysfunction. The researchers gave these volunteers, split nearly equally between men and women, echocardiograms to measure heart structure and function. This echocardiogram included traditional Doppler measures, as well as cutting edge tissue Doppler imaging and 2D speckle tracking imaging, two newer technologies that give more detailed views of the heart.
Over the next 12 weeks, these volunteers each took daily omega-3 supplements containing 1.9 grams EPA and 1.5 grams DHA. The researchers then repeated the echocardiograms.
Results show that between the first and second scans, the volunteers had no detectable improvements in diastolic function, says study leader Kevin Monahan, Ph.D., suggesting that fish oil didn't change this important parameter of cardiac health.
Keep Up the Fish Oil
However, Monahan says, the results shouldn't deter people from taking fish oil or other omega-3 supplements for heart health. "I don't think there's any reason to stop taking fish oil based on our data," he says. "From a big picture standpoint, we know that consumption of fish and fish oil reduces cardiac disease risk and mortality. Just because omega-3 supplements doesn't improve diastolic function over 12 weeks in this population doesn't mean that these nutrients don't exert other important cardiac effects."
He notes that a longer trial may produce more noticeable results on diastolic function, or that omega-3 fatty acids may produce more profound effects on other aspects of heart function, preventing heart disease in other ways.
Diastolic dysfunction can be a harbinger of heart failure, Monahan says, causing symptoms including shortness of breath and severe fatigue with physical activity. Heart failure is a prevalent and expensive condition in the U.S., with estimated costs in the tens of billions of dollars.
Provided by
Federation of American Societies for Experimental Biology
-
Omega-3 supplements no help against repeat heart trouble: review
Apr 09, 2012 |
not rated yet |
0
-
Fish oil supplements boost mental performance: study
Oct 25, 2011 |
not rated yet |
0
-
Food scientists fortify goat cheese with fish oil to deliver healthy omega-3 fatty acids
Feb 16, 2012 |
not rated yet |
0
-
Low levels of omega-3 fatty acids may cause memory problems
Feb 27, 2012 |
not rated yet |
0
-
Omega-3 fatty acids may help to reduce the physical harm caused by smoking
Apr 20, 2012 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Rotating electron as a dipole is this right?
1 hour ago
-
Dipole term in multipole expansion
5 hours ago
-
Bubbles in a Pre-Boiling/Boiling pot of water
7 hours ago
-
Assumptions of Griffith's fracture theory
17 hours ago
-
Current leading voltage or vice versa concept
19 hours ago
-
Angular Frequency of AC voltage
22 hours ago
- More from Physics Forums - Classical Physics
More news stories
Biodegradable stent proves non-inferior to drug-eluting stent
The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...
Cardiology
2 hours ago |
not rated yet |
0
Post-approval TAVI registry shows high rates of device success at one year
One-year results from SOURCE XT – one of the largest, post-approval transcatheter aortic valve implantation (TAVI) registries to-date – reported today at EuroPCR 2013 show good clinical outcomes in routine clinical practice, ...
Cardiology
2 hours ago |
not rated yet |
0
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Cardiology
4 hours ago |
not rated yet |
0
|
Study identifies superior hypertension treatment, efficacy between sexes
(Medical Xpress)—In a recent subgroup analysis of the largest blood pressure treatment trial in history, University of Alabama at Birmingham (UAB) researchers found that women and men react the same to ...
Cardiology
12 hours ago |
5 / 5 (1) |
0
Evaluating a new way to open clogged arteries
Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments ...
Cardiology
12 hours ago |
4.8 / 5 (4) |
0
|
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
Changing cancer's environment to halt its spread
By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...
Apr 25, 2012
Rank: not rated yet